The Liverpool-based ALG International Holdings, headquartered in Speke, is aiming to focus on foreign markets and international expansion next year after notable international sales growth.

Operating eight medical product brands, ALG International Holdings covers equipment for orthotics and prosthetics, podiatry and physiotherapy and rehabilitation. These brands include diabetic foot brand Diaped, as well as Podotech and Slimflex; providing foot care specialists with a range of innovative products. ALG also operate Aortha, which offers state-of-the-art material technology for use in the prosthetics and orthotics sector.

The reported turnover for ALG over the last year to August 31  has been £11 million, an increase on £10.7 million reported in the previous year. ALG noted that its offices in Los Angeles and Dubai had seen particular year-on-year revenue increases, at 54% and 48% respectively. ALG’s Melbourne office also reported growth of 20%.

In the last year, ALG has also seen its total number of staff increase from 81 to 94.

Hugh Sheridan, chief executive of ALG said:

“ALG has built a reputation not only as a provider of industry-leading medical products, but increasingly as a leader in innovation and technology.

“We are excited by the future potential not only in the UK but also overseas where our offices in Australia, the US and the United Arab Emirates are seeing substantial year-on-year growth.

“ALG will continue to develop and bring to market life-changing products that not only change the way people move, but also the way they feel.”

On top of current operations, ALG continues to invest in research and development of its product lines, both existing and new, with the ALG team employing many experienced medical professionals and clinicians.

Source

Image Credit

Words: Peter Cribley